ClinicalCodes.org

An online clinical codes repository to improve validity and reproducibility of medical database research

Research article:

Suicide risk linked with clinical consultation frequency, psychiatric diagnoses and psychotropic medication prescribing in a national study of primary care patients

Reference:

Kirsten Windfuhr, David While, Nav Kapur, Darren M. Ashcroft, Evangelos Kontopantelis, Matthew J. Carr, Jenny Shaw, Louis Appleby, Roger T. Webb (2016) Suicide risk linked with clinical consultation frequency, psychiatric diagnoses and psychotropic medication prescribing in a national study of primary care patients. Psychological Medicine, doi:

Link to article
Abstract
Background: Little is known about the precursors of suicide risk among primary care patients. Objectives: To examine risk of suicide in relation to recent general practice consultation patterns, psychiatric diagnoses and the prescribing of multiple psychotropic drug types. Methods: Nested case-control study in the Clinical Practice Research Datalink (CPRD), England. Patients aged 16 years and older who died by suicide during 2002-2011 (N=2384) were matched on gender, age and registered practice with up to 20 living control patients (N=46,899). Results: Risk of dying by suicide was raised among general practice non-attenders, and increased sharply with rising number of clinical consultations compared with patients who consulted once only in the year preceding suicide. Markedly elevated risk was also associated with the prescribing of multiple psychotropic medication types and with having several psychiatric diagnoses, and to a lesser degree risk was also raised among patients living in more socially deprived residential areas. In a multivariable model the confounding effect of multiple psychotropic drug types largely accounted for the rising risk gradient observed with increasing clinical consultation frequency. Conclusion: A greater proportion of patients with several psychiatric diagnoses, those prescribed multiple psychotropic medication types, and those who consult at very high frequency might be considered for referral to mental health services by their general practitioners. Non-attenders are also at increased risk, which suggests that conventional models of primary care may not be effective in meeting the needs of all people in the community experiencing major psychosocial difficulties and at elevated risk of suicide.
Author for correspondence
Roger Webb
Email for correspondence
roger.webb@manchester.ac.uk

Code list: res38: Anxiolitics

40 codes in list

Code Coding system Description Entity type List name
39801020 Multilex Zimovane 7.5mg tablets (Lexon (UK) Ltd) drug res38: Anxiolitics
479021 Multilex Zopiclone 3.75mg/5ml oral solution drug res38: Anxiolitics
59209020 Multilex Zopiclone 7.5mg tablets (Actavis UK Ltd) drug res38: Anxiolitics
59210020 Multilex Zopiclone 3.75mg tablets (Actavis UK Ltd) drug res38: Anxiolitics
59236020 Multilex Zopiclone 3.75mg tablets (IVAX Pharmaceuticals UK Ltd) drug res38: Anxiolitics
59237020 Multilex Zopiclone 7.5mg tablets (IVAX Pharmaceuticals UK Ltd) drug res38: Anxiolitics
59593020 Multilex Zopiclone 3.75mg tablets (Teva UK Ltd) drug res38: Anxiolitics
59594020 Multilex Zopiclone 7.5mg tablets (Teva UK Ltd) drug res38: Anxiolitics
59784020 Multilex Zopiclone 7.5mg tablets (Generics (UK) Ltd) drug res38: Anxiolitics
59785020 Multilex Zopiclone 3.75mg tablets (Generics (UK) Ltd) drug res38: Anxiolitics
60509020 Multilex Zopiclone 3.75mg tablets (A A H Pharmaceuticals Ltd) drug res38: Anxiolitics
60510020 Multilex Zopiclone 7.5mg tablets (A A H Pharmaceuticals Ltd) drug res38: Anxiolitics
62715020 Multilex Zopiclone 7.5mg tablets (Sandoz Ltd) drug res38: Anxiolitics
63436020 Multilex Zopiclone 7.5mg tablets (Kent Pharmaceuticals Ltd) drug res38: Anxiolitics
63765020 Multilex Zopiclone 7.5mg tablets (PLIVA Pharma Ltd) drug res38: Anxiolitics
63881020 Multilex Zolpidem 5mg Tablet (Winthrop Pharmaceuticals Ltd) drug res38: Anxiolitics
63882020 Multilex Zolpidem 10mg Tablet (Winthrop Pharmaceuticals Ltd) drug res38: Anxiolitics
64484020 Multilex Zolpidem 5mg tablets (Teva UK Ltd) drug res38: Anxiolitics
64487020 Multilex Zolpidem 10mg tablets (Teva UK Ltd) drug res38: Anxiolitics
64733020 Multilex Zolpidem 5mg tablets (A A H Pharmaceuticals Ltd) drug res38: Anxiolitics
64738020 Multilex Zolpidem 10mg tablets (A A H Pharmaceuticals Ltd) drug res38: Anxiolitics
65546020 Multilex Zopiclone 3.75mg tablets (Kent Pharmaceuticals Ltd) drug res38: Anxiolitics
65832020 Multilex Zolpidem 5mg tablets (IVAX Pharmaceuticals UK Ltd) drug res38: Anxiolitics
65835020 Multilex Zolpidem 10mg tablets (IVAX Pharmaceuticals UK Ltd) drug res38: Anxiolitics
66946020 Multilex Zolpidem 10mg tablets (Generics (UK) Ltd) drug res38: Anxiolitics
72408020 Multilex Zimovane 7.5mg tablets (Sanofi) drug res38: Anxiolitics
72416020 Multilex Zopiclone 7.5mg tablets drug res38: Anxiolitics
72417020 Multilex Zopiclone 3.75mg tablets drug res38: Anxiolitics
75692020 Multilex Zolpidem 5mg tablets drug res38: Anxiolitics
75693020 Multilex Zolpidem 10mg tablets drug res38: Anxiolitics
75696020 Multilex Stilnoct 5mg tablets (Sanofi) drug res38: Anxiolitics
75697020 Multilex Stilnoct 10mg tablets (Sanofi) drug res38: Anxiolitics
83069020 Multilex Zimovane LS 3.75mg tablets (Sanofi) drug res38: Anxiolitics
85821020 Multilex Zileze 3.75 tablets (Opus Pharmaceuticals Ltd) drug res38: Anxiolitics
85822020 Multilex Zileze 7.5 tablets (Opus Pharmaceuticals Ltd) drug res38: Anxiolitics
86240020 Multilex Zaleplon 5mg capsules drug res38: Anxiolitics
86241020 Multilex Zaleplon 10mg capsules drug res38: Anxiolitics
86243020 Multilex Sonata 5mg capsules (Meda Pharmaceuticals Ltd) drug res38: Anxiolitics
86244020 Multilex Sonata 10mg capsules (Meda Pharmaceuticals Ltd) drug res38: Anxiolitics
91009020 Multilex Zopiclone 3.75mg/5ml oral suspension drug res38: Anxiolitics

0 comments have been posted.

Please log in to leave a comment.